insider24.ch
Company / strategic investorRegistered location :PrattelnGroup :Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AGDeclared Swiss shareholdings

Santhera Pharmaceuticals Schweiz AG: 0 Swiss companies with a declared holding.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
—
Swiss companies held
0
Largest position
—
12-month trend
Not determinable
0 rate rises · 0 rate falls
Latest filing
…

Declared Swiss portfolio

Latest declared rate per company

No active declared position.

How to read these figures?

Rates come from the 45 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure1 controlled by

Controlled by

Group entities that file jointly with this shareholder as its head.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 0

90 days · Downward crossings

0

visible history: 0

First disclosure: —Last disclosure: —

Latest shareholding disclosures

SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

39.76%Voting rights sold03.08.2023
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

75.87%Voting rights sold26.07.2023
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

73.74%Voting rights sold05.07.2023
Show 36 older disclosures
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

72.83%Voting rights sold29.06.2023
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

72.83%Voting rights sold24.06.2023
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

97.06%Voting rights sold07.03.2023
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

55%Voting rights sold18.03.2022
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

69.65%Voting rights sold17.03.2022
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

77.02%Voting rights sold01.10.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

52.27%Voting rights sold07.09.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

67.54%Voting rights sold24.08.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

66.07%Voting rights sold07.08.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

60.67%Voting rights sold08.06.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

78.23%Voting rights sold28.05.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

77.54%Voting rights sold27.05.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

84.3%Voting rights sold18.05.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

91.7%Voting rights sold11.05.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

87.91%Voting rights sold07.05.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

97.72%Voting rights sold29.04.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

94.17%Voting rights sold24.04.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

40.01%Voting rights sold14.04.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

49.57%Voting rights sold09.04.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

52.54%Voting rights sold07.04.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

56.99%Voting rights sold26.03.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

58.49%Voting rights sold17.03.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

60.92%Voting rights sold06.03.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

61.51%Voting rights sold04.03.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

51.68%Voting rights sold23.02.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

43.21%Voting rights sold11.02.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

53.28%Voting rights sold21.01.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

59.61%Voting rights sold02.12.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

85.05%Voting rights sold07.11.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

71.8%Voting rights sold29.10.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

58.42%Voting rights sold19.09.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

63.42%Voting rights sold21.07.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

64.32%Voting rights sold07.07.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

65.39%Voting rights sold23.06.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

53.79%Voting rights sold17.04.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Schweiz AG · Single shareholder

29.36%Voting rights sold21.02.2018

insider24.ch

Follow Santhera Pharmaceuticals Schweiz AG’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Common questions

Which Swiss companies are in Santhera Pharmaceuticals Schweiz AG’s disclosed portfolio?

No active holding identified in available disclosures.

What is Santhera Pharmaceuticals Schweiz AG’s latest disclosure?

The latest available disclosure was published on 03.08.2023 and concerns Santhera Pharmaceuticals Holding AG. Threshold disclosures do not describe every purchase or sale.

Explore further

Recent insider purchases

What are insiders doing at companies disclosed by this shareholder?

All purchases this week

Insider barometer

Compare insider purchases and sales across the Swiss stock exchange over 30 days.

View the Swiss barometer

These signals are not investment advice.